Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2009, 55, 116-118

https://doi.org/10.14712/fb2009055030116

Apolipoprotein E Arg136 → Cys in Individuals with Premature Myocardial Infarction

Jaroslav A. Hubáček1,2,3, R. Poledne1,3, J. Piťha1,3, M. Aschermann4, H. Skalická4, V. Staněk3

1Cardiovascular Research Centre, Prague, Czech Republic
2Faculty of Public Health and Social Studies, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic
3Institute for Clinical and Experimental Medicine, Prague, Czech Republic
4Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, 2nd Department of Internal Medicine, Prague, Czech Republic

Received February 2009
Accepted April 2009

References

1. Davignon, J., Gregg, R. E., Sing, C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8, 1-21.
2. Feussner, G., Albanese, M., Mann, W. A., Valencia, A., Schuster, H. (1996) Apolipoprotein E2 (Arg136→Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia. Eur. J. Clin. Invest. 26, 13-23. <https://doi.org/10.1046/j.1365-2362.1996.83232.x>
3. Gerdes, L. U., Klausen, I. C., Sihn, I., Faergeman, O. (1992) Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study population around the world. Genet. Epidemiol. 9, 155-167. <https://doi.org/10.1002/gepi.1370090302>
4. Hixson, J. E., Vernier, D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548. <https://doi.org/10.1016/S0022-2275(20)43176-1>
5. Hubacek, J. A., Pitha, J., Stávek, P., Poledne, R. (2000) Variable expression of hypercholesterolemia in apolipoprotein E2* (Arg136→Cys) heterozygotes. Physiol. Res. 49, 307-314. <https://doi.org/10.33549/physiolres.930000.49.307>
6. Hubacek, J. A., Pitha, J., Skodova, Z., Poledne, R. (2002) Rare variant of apolipoprotein E (Arg136→Cys) in a subject with normal lipid values. Physiol. Res. 51, 107-108. <https://doi.org/10.33549/physiolres.930148>
7. Hubacek, J. A., Adamkova, V., Skodova, Z. (2005) Rare variant of apolipoprotein E (Arg136→Ser) in two normolipidemic individuals. Physiol. Res. 54, 573-575. <https://doi.org/10.33549/physiolres.930687>
8. Hubacek, J. A., Adamkova, V., Stavek, P., Kubinova, R., Peasey, A., Pikhart, H., Marmot, M., Bobak, M. (2008) Apolipoprotein E Arg136→Cys mutation and hyperlipidemia in a large central European population sample. Clin. Chim. Acta 388, 217-218. <https://doi.org/10.1016/j.cca.2007.10.009>
9. März, W., Hoffmann, M. M., Scharnagl, H., E. Fisher, M. Chen, M. Nauck, G. Feussner, H. Wieland (1998) Apolipoprotein E (Arg136→Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia. J. Lipid Res. 39, 658-669. <https://doi.org/10.1016/S0022-2275(20)33303-4>
10. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215. <https://doi.org/10.1093/nar/16.3.1215>
11. Minnich, A., Weisgraber, K. H., Newhouse, Y., Dong, L. M., Fortin, L. J., Tremblay, M., Davignon, J. (1995) Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3’ (Arg136→His): association with mild dyslipidemia and double pre-β very low density lipoproteins. J. Lipid Res. 36, 57-66. <https://doi.org/10.1016/S0022-2275(20)39754-6>
12. Pocovi, M., Cenarro, A., Civiera, F., Myers, R. H., Casao, E., Esteban, M., Ordovas, J. M. (1996) Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E (Arg136→Ser) variant in multigenerational pedigree studies. Atherosclerosis 122, 33-46. <https://doi.org/10.1016/0021-9150(95)06745-0>
13. Svobodova, H., Kucera, F., Stulc, T., Vrablik, M., Amartuvshin, B., Altannavch, T. S., Ceska, R. (2007) Apolipoprotein E gene polymorphism in the Mongolian population. Folia Biol. (Praha) 53, 138-142.
14. Talmud, P. J., Stephens, J. W., Hawe, E., Demissie, S., Cupples, L. A., Hurel, S. J., Humphries, S. E., Ordovas, J. M. (2005) The significant increase in cardiovascular disease risk in APOEε4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann. Hum. Genet. 69, 613-622. <https://doi.org/10.1111/j.1529-8817.2005.00205.x>
15. Walden, C. C., Huff, M. W., Leiter, L. A., Connelly, P. W., Hegele, A. (1994) Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping. J. Clin. Endocrinol. Metab. 78, 699-704.
16. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., Agard, D. A. (1991) Three-dimensional structure of the LDL-receptor-binding domain apolipoprotein E. Science 252, 1817-1822. <https://doi.org/10.1126/science.2063194>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive